Annals of Clinical Neurophysiology

  • 제11권1호
  • /
  • Pages.24-27
  • /
  • 2009
  • /
  • 2508-691X(pISSN)
  • /
  • 2508-6960(eISSN)
대한임상신경생리학회 (The Korean Society of Clinical Neurophysiology)
권호 표지

루프스 신염 치료로 Cyclosporine 투여 후 발생한 가역성후백질뇌병증 증후군

A case of Reversible Posterior Leukoencephalopathy Syndrome in Lupus Nephritis Treated with Cyclosporine

  • 나상준 (건양대학교 의과대학 신경과학교실) ;
  • 이기욱 (건양대학교 의과대학 신경과학교실)
  • Na, Sang-Jun (Department of Neurology, Konyang University College of Medicine) ;
  • Lee, Kee-Ook (Department of Neurology, Konyang University College of Medicine)
  • 투고 : 2008.05.27
  • 심사 : 2008.11.25
  • 발행 : 2009.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Reversible posterior leukoencephalopathy syndrome (RPLS) is an acute encephalopathy, usually characterized by seizures, visual disorder, mental change and reversible posterior white and gray matter lesions on brain magnetic resonance imaging (MRI). Conditions commonly associated with RPLS include acute renal failure, eclampsia, hypertension, immunosuppresion state, and use of intravenous immunoglobulin or chemotherapy, and additional contributing factors. We report the case of RPLS associated with cyclosporine use in lupus nephritis. In this case, it was not clearly elucidated which was main cause of RPLS. We could think RPLS developed maybe due to combined effect of cyclosporine and lupus nephritis.

키워드

참고문헌

  1. Hinchey J, Chaves C, Appignani B, et al. A reversible posteri-or leukoencephalopathy syndrome. N Engl J Med 1996;334: 494-500. https://doi.org/10.1056/NEJM199602223340803
  2. Primavera A, Audenino D, Mavilio N, Cocito L. Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis. Ann Rhem Dis 2001;60:534-537. https://doi.org/10.1136/ard.60.5.534
  3. Park MC, Park YB, Moon JY, et al. Reversible Posterior Leukoencephalopathy Syndrome in a Patient with Systemic Lupus Erythematosus. J Korean Rheum Assoc 2002;9:335-340.
  4. Shin KC, Choi HJ, Bae YD, Lee JC, Lee EB, Song YW. Reversible posterior leukoencephalopathy syndrome in sys-temic lupus erythematosus with thrombocytopenia treated with cyclosporine. J Clin Rheumatol 2005;11:164-166. https://doi.org/10.1097/01.rhu.0000164825.63063.43
  5. Magnano MD, Bush TM, Herrera I, Altman RD. Reversible posterior leukoencephalopathy in patients with systemic lupus erythematosus. Semin Arthritis Rhem 2006;35:396-402. https://doi.org/10.1016/j.semarthrit.2006.01.002
  6. Min L, Zwerling J, Ocava LC, Chen IH, Putterman C. Rever-sible posterior leukoencephalopathy in connective tissue di-seases. Semin Arthritis Rheum 2006;35:385-395.
  7. Sheth RD, Riggs JE, Bodenstenier JB, Gutierrez AR, Ketonen LM, Ortiz OA. Parietal occipital edema in hypertensive ence-phalopathy: a pathogenic mechanism. Eur Neurol 1996;36:25-28. https://doi.org/10.1159/000117195
  8. Jennekens FG, Kater L. The central nervous system in sys-temic lupus erythematosus. Part 1. Clinical syndromes: a liter-ature investigation. Rheumatology (Oxford) 200241:605-618. https://doi.org/10.1093/rheumatology/41.6.605
  9. Leroux G, Sellam J, Costedoat-Chalumeau N, Le Thi Huong D, Combes A, Tieulié N, Haroche J, Amoura Z, Nieszkowska A, Chastre J, Dormont D, Piette JC. Posterior reversible ence-phalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus 2008;17: 139-147. https://doi.org/10.1177/0961203307085405
  10. Covarrubias DJ, Luetmer PH, Campeau NG. Posterior rever-sible encephalopathy syndrome: prognostic utility of quantita-tive diffusion-weighted MR images. AJNR Am J Neuroradiol 2002;23:1038-1048.